Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Aug 1;210(3):251-252.
doi: 10.1164/rccm.202404-0707ED.

Strategies for Identifying Biomarkers in Severe Asthma

Pierre-Olivier Girodet  1   2   3
Affiliations
Editorial

Strategies for Identifying Biomarkers in Severe Asthma

Pierre-Olivier Girodet. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study.
    Djukanović R, Brinkman P, Kolmert J, Gomez C, Schofield J, Brandsma J, Shapanis A, Skipp PJS, Postle A, Wheelock C, Dahlen SE, Sterk PJ, Brown T, Jackson DJ, Mansur A, Pavord I, Patel M, Brightling C, Siddiqui S, Bradding P, Sabroe I, Saralaya D, Chishimba L, Porter J, Robinson D, Fowler S, Howarth PH, Little L, Oliver T, Hill K, Stanton L, Allen A, Ellis D, Griffiths G, Harrison T, Akenroye A, Lasky-Su J, Heaney L, Chaudhuri R, Kurukulaaratchy R; SoMOSA study team and the U-BIOPRED study team. Djukanović R, et al. Am J Respir Crit Care Med. 2024 Aug 1;210(3):288-297. doi: 10.1164/rccm.202310-1730OC. Am J Respir Crit Care Med. 2024. PMID: 38635834 Free PMC article.

References

    1. Israel E, Reddel HK. Severe and difficult-to-treat asthma in adults. N Engl J Med . 2017;377:965–976. - PubMed
    1. Porsbjerg C, Melén E, Lehtimäki L, Shaw D. Asthma. Lancet . 2023;401:858–873. - PubMed
    1. Wu AC, Kiley JP, Noel PJ, Amur S, Burchard EG, Clancy JP, et al. Current status and future opportunities in lung precision medicine research with a focus on biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute research statement. Am J Respir Crit Care Med . 2018;198:e116–e136. - PMC - PubMed
    1. Narendra D, Blixt J, Hanania NA. Immunological biomarkers in severe asthma. Semin Immunol . 2019;46:101332. - PubMed
    1. Kroes JA, Zielhuis SW, van Roon EN, Ten Brinke A. Prediction of response to biological treatment with monoclonal antibodies in severe asthma. Biochem Pharmacol . 2020;179:113978. - PubMed